生物植入物市场战略、顶级参与者、增长机会、2031 年分析和预测

  • Report Code : TIPHE100001101
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

 

[研究报告] 2023 年生物植入物市场价值为 1178.2 亿美元,预计到 2031 年将达到 2230.6 亿美元;预计 2023-2031 年期间的复合年增长率为 8.3%。

 

分析师观点:

报告根据当前生物植入物市场趋势和影响生物植入物市场增长的驱动因素,介绍了增长前景。生物植入物市场规模增长的主要因素包括慢性病病例的增加(尤其是老年人口)和可支配收入的增加。发达国家和发展中国家的医疗保健基础设施预计将进一步改善,从而大大推动生物植入物市场的发展。

全球民众对美容植入物有效性和技术进步的认识不断提高。由于牙科问题病例的增加,全球生物植入物市场正在增长。由于心血管和骨科问题发病率的上升,对骨科植入物和起搏器的需求也在增加。由于北美强大的医疗保健基础设施、人们对美容植入物的认识不断提高以及该地区生物植入物市场的主要参与者,预计生物植入物控制在北美的整体销售额将增长。此外,由于医疗保健技术的快速进步、对非侵入性生物植入物的需求增加以及老年人口的激增,欧洲是全球第二大生物植入物市场。然而,生物植入手术成本的增加和生物植入产品的适当利用阻碍了生物植入物市场的增长。

 

市场概况:

推动生物植入物市场增长的关键因素包括老年人骨质疏松症病例的增加、对微创手术的需求不断增长以及生活方式障碍病例的增加。此外,医疗保健领域的技术发展预计将对未来几年的生物植入物市场预测产生重大影响。尽管医疗保健行业多年来取得了重大的技术进步,但严重疾病发病率的上升阻碍了生物植入物市场的发展。

 

定制此报告以满足您的需求

您可以免费定制任何报告,包括本报告的部分内容、国家级分析、Excel 数据包,以及为初创企业和大学提供优惠和折扣

生物植入物市场:

Bio-Implants Market
  • 获取此报告的关键市场趋势。
    这个免费样品将包括数据分析,从市场趋势到估计和预测。

 

 

市场驱动因素:

 

 

生活方式障碍负担加重推动市场增长

 

糖尿病、心血管疾病和骨关节炎等生活方式障碍在世界范围内日益普遍,是发病率和死亡率的主要原因。生物植入物(例如支架和脚手架)可以治疗这些疾病,并且正在成为传统永久性植入物的有吸引力的替代品。根据美国心脏协会 2021 年发表的一篇文章,美国每年约有 40,000 名儿童接受先天性心脏手术。英国心脏基金会 2022 年发布的“2022 年 1 月英国情况说明书”指出,2021 年约有 760 万人患有心脏和循环系统疾病,近 400 万男性和 360 万女性患有心脏病和循环系统疾病。因此,心血管疾病的日益流行导致对早期诊断和治疗的需求日益增加,这预计将推动对介入心脏病学手术以及心血管植入物生物植入物的需求。此外,口腔健康问题的惊人增长预计将增加对生物植入物的需求。例如,根据世界卫生组织(WHO)2021年全球疾病负担研究,口腔疾病预计将影响全球约一半的人口。约有35.8亿人受到龋齿和其他牙齿问题的影响。生物植入物

此外,生物植入物有助于管理和控制肌肉骨骼疾病等疾病中的特定药物输送。根据《骨科》杂志 2021 年 1 月发表的一篇文章,北京社区中年人腰椎滑脱的总体患病率为 17.26%(男性 15.98%,女性 18.80%)。60 岁及以上的女性更容易患腰椎滑脱。根据世界卫生组织的数据,肌肉骨骼损伤和疾病非常普遍,影响着全球 17.1 亿人,是导致全球残疾的主要原因。根据《柳叶刀风湿病学》发表的一项新研究,到 2050 年,预计将有超过 10 亿人患有关节、肌肉、骨骼、韧带、肌腱和脊柱疾病,而 2020 年这一数字约为 5 亿。由于人口老龄化加剧,患有肌肉骨骼疾病和相关功能障碍的人数正在迅速增加。患者中肌肉骨骼疾病的增多导致对植入手术和住院治疗的需求增加,从而推动了生物植入物市场的发展。

 

节段分析:

 

生物植入物市场分析通过考虑以下几个部分来进行:类型、材料和最终用户。

根据类型,生物植入物市场细分为心血管植入物、骨科植入物、牙科植入物、眼科植入物等。心血管植入物细分市场在 2023 年占据了更大的市场份额。该细分市场的增长归因于研发新型心脏植入物产品的研发活动的快速增长。例如,2022 年 2 月,医疗技术公司雅培宣布,作为其 AVEIR DR i2i 关键临床试验的一部分,世界上首例患者植入了无导线双腔起搏器系统。雅培实验性双腔无导线起搏器的植入代表了无导线起搏器技术的一个重要技术里程碑;这是世界上第一个进行关键试验的起搏器。

根据材料,生物植入物市场分为金属、陶瓷和聚合物。速释胶囊部分在 2023 年占据了最大的市场份额。预计在预测期内,其复合年增长率将达到最高。这些金属具有出色的机械强度、耐腐蚀性和生物相容性,是植入应用的理想选择。钛是一种非常受欢迎的骨科、牙科和心血管植入物材料,因为它具有出色的耐用性、轻巧的设计和与人体组织的兼容性。由于金属具有延展性、导电性和惰性,因此在心脏电极和神经探针等专门的植入物应用中受到重视。慢性病发病率的不断上升以及材料科学和制造技术的进步推动了对生物植入物中生物材料金属的需求。这巩固了生物材料金属作为生物植入物市场最受欢迎的材料类别的地位。

根据最终用户,市场分为医院和诊所以及门诊手术中心。医院和诊所部门在 2023 年占据了更大的生物植入物市场份额,预计在 2023-2031 年期间将实现更高的复合年增长率。医院和诊所通常吸引大量患者,包括需要专门植入治疗的患者,因为它们拥有广泛的医疗计划和多学科的患者护理方法。医院通常与研究中心和医疗器械制造商合作,以方便获得尖端的植入物突破和技术。医院和诊所是生物植入物市场的重要参与者,因为它们提供必要的植入物相关服务,并对与生物植入物相关的商品和流程产生大量需求。因此,随着人们对药物的需求不断增长,医院和诊所的数量不断增加,预计将在预测期内支持该细分市场的增长。

 

区域分析:

 

生物植入物市场报告的范围包括北美、欧洲、亚太地区、中东和非洲以及南美和中美洲。2023 年北美市场价值为 505.1 亿美元,预计到 2031 年将达到 966.9 亿美元;预计 2023-2031 年期间的复合年增长率为 8.5%。北美市场分为美国、加拿大和墨西哥。北美市场的增长归因于慢性病患病率的上升和医疗基础设施的改善。2022 年 7 月,美国疾病控制和预防中心 (CDC) 的最新数据显示,冠状动脉疾病是最常见的心脏病类型之一,美国约有 2010 万 20 岁及以上的成年人患有该疾病。此外,根据 CDC 的数据,每 40 秒就有一个人心脏病发作,即近 805,000 人。预计预测期内慢性病数量的增加将增加对生物植入物的总体需求。

根据医疗保险和医疗补助服务中心的数据,到 2028 年,全国医疗保健支出预计将达到 6.2 万亿美元,2019 年至 2028 年的平均年增长率 (AAR) 为 5.4%。由于全国医疗保健支出预计将增加 1.1%,预计 2028 年医疗保健在经济中的份额将增加 19.7%,高于 2019-2028 年的平均年 GDP。因此,预计医疗保健支出的增加将为市场参与者在预测期内开发生物植入物创造机会。

2023 年,欧洲占据第二大生物植入物市场份额。该地区市场的增长归因于医疗保健技术的进步、对非手术生物植入物的需求增加以及老年人口的增长。欧洲市场的增长归因于政府对医疗保健的资助和支持、骨科疾病发病率的增加以及医疗保健研发活动的增加。此外,由于该地区心血管疾病发病率的增加导致心血管手术数量增加,推动了该地区生物植入物市场的发展。

预计 2023-2031 年期间,亚太地区将在全球生物植入物市场中实现最高的复合年增长率。该地区市场的增长归因于老年人口的增长、可支配收入的增加、医疗保健投资的增加和市场参与者的扩张,以及由于交通事故数量的增加导致脊髓损伤病例的增加。亚太地区正在经历显着的增长,尤其是在中国和印度等新兴市场。扩大医疗保健基础设施和增加对该领域的投资以提供高效的患者服务推动了该地区生物植入物市场的发展。例如,根据日本庆应义塾大学 2019 年的一份出版物,日本约有 100,000 名患者因脊髓损伤而瘫痪。然而,iPS 技术的批准预计将在不久的将来帮助该国的这些患者,这可能会在未来几年为生物植入物市场提供机会。据联合国亚洲经济社会委员会和太平洋社会发展部统计,2016年亚洲60岁以上人口占总人口的12.4%以上,预计到2050年底将达到13亿。

 

生物植入物

生物植入物市场区域洞察

Insight Partners 的分析师已详尽解释了预测期内影响生物植入物市场的区域趋势和因素。本节还讨论了北美、欧洲、亚太地区、中东和非洲以及南美和中美洲的生物植入物市场细分和地理位置。

Bio-Implants Market
  • 获取生物植入物市场的区域特定数据

生物植入物市场报告范围

报告属性细节
2023 年的市场规模1178.2亿美元
2031 年市场规模2230.6亿美元
全球复合年增长率(2023 - 2031)8.3%
史料2021-2023
预测期2023-2031
涵盖的领域按类型
  • 心血管植入物
  • 骨科植入物
  • 牙科植入物
  • 眼科植入物
按材质
  • 金属
  • 陶瓷
  • 聚合物
由最终用户
  • 医院、诊所和门诊手术中心
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  • LifeNet 健康
  • 施乐辉
  • Arthrex 公司
  • 莱曼尼克诊所
  • Alpha 生物技术公司
  • MiMedx 集团
  • 美敦力
  • 圣犹达医疗(雅培)
  • 史赛克合作组织

 

生物植入物市场参与者密度:了解其对业务动态的影响

生物植入物市场正在快速增长,这得益于终端用户需求的不断增长,而这些需求又源于消费者偏好的不断变化、技术进步以及对产品优势的认识不断提高等因素。随着需求的增加,企业正在扩大其产品范围,进行创新以满足消费者的需求,并利用新兴趋势,从而进一步推动市场增长。

市场参与者密度是指在特定市场或行业内运营的企业或公司的分布情况。它表明在给定市场空间中,相对于其规模或总市场价值,有多少竞争对手(市场参与者)存在。

在生物植入物市场运营的主要公司有:

  1. LifeNet 健康
  2. 施乐辉
  3. Arthrex 公司
  4. 莱曼尼克诊所
  5. Alpha 生物技术公司

免责声明上面列出的公司没有按照任何特定顺序排列。


Bio-Implants Market

 

  • 获取生物植入物市场顶级关键参与者概览

 

 

关键球员分析:

 

LifeNet Health;Smith & Nephew;Arthrex, Inc.;Clinic Lemanic;Alpha Bio Tec;MiMedx Group;Medtronic;St Jude Medical (Abbott);Stryker Cooperation;DePuy Synthes;Biomet (Zimmer);Exactech, Inc.;Cochlear Ltd 和 Straumann AG 是生物植入物市场报告中介绍的关键参与者。

 

最新动态:

 

在市场上运营的公司采用并购等方式。根据公司新闻稿,以下是最近的一些关键发展:

  • 2023 年 2 月,用于修复弯曲骨骼骨折的医疗器械开发商 CurvaFix, Inc. 宣布推出直径较小的 7.5 毫米——CurvaFix IM 植入物。该植入物旨在简化手术程序,并在小骨骼中提供牢固、稳定的固定,旨在使骨骼患者能够。
  • 2022年6月,ZimVie在美国获得了食品药品监督管理局(FDA)的批准,T3专业设计植入物和Encode Emergence愈合基台在美国上市。
  • 2021 年 6 月,医疗器械公司 Intelligent Implants Ltd. 的骨科植入技术 SmartFuse 获得了美国 FDA 的突破性批准。SmartFuse 平台旨在远程刺激、控制和监测骨骼生长,以做出实时临床决策。该产品适用于首次接受腰椎融合术的患者。
  • 2021年2月,美敦力推出了TYRX可吸收抗菌鞘,这是一种可吸收的一次性抗菌鞘,旨在稳定心脏植入式电子设备或植入式神经刺激器。
  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are the growth estimates for the bio implants market till 2031?

The bio implants market is expected to be valued at US$ 223.06 billion in 2031.

Which segment is dominating the bio implants market?

The global bio implants market, based on type, the bio implants market is segmented into cardiovascular implants, orthopedic implants, dental implants, ophthalmic implants, and others. The cardiovascular implants segment held the largest bio implants market share in 2023; it is also expected to register the highest CAGR during 2023–2031. The bio implants market, based on material, is segmented into metals, ceramics, and polymers. The metals segment held the largest bio implants market share in 2023. It is further expected to register the highest CAGR from 2023 to 2031. Based on end user, the market is bifurcated into hospitals & clinics and ambulatory surgical centers. The hospitals & clinics segment accounted for a larger market share in 2023. The same segment is anticipated to register a higher CAGR during 2023–2031.

Who are the major players in the bio implants market?

The bio implants market majorly consists of the players such as LifeNet Health; Smith & Nephew; Arthrex, Inc.; Clinic Lemanic; Alpha Bio Tec; MiMedx Group; Medtronic; St Jude Medical (Abbott); Stryker Cooperation; DePuy Synthes; Biomet (Zimmer); Exactech, Inc.; Cochlear Ltd; and Straumann AG.

What are the driving factors for the bio implants market?

The factors driving the growth of the bio implants market include the increasing burden of lifestyle disorders and the growing demand for minimally invasive surgical procedures.

What are bio implants?

Bio implants are designed to repair the physiological function of a damaged biostructure. The implantation method replaces; supports; and improves a missing, damaged, or existing biological structure. The bio implants market report emphasizes the key factors impacting the market and showcases the developments of prominent players. Increasing incidences of bone loss in the geriatric population, growing demand for minimally invasive surgeries, rising cases of lifestyle disorders, and technological innovations in the healthcare sector are a few factors contributing to the growing bio implants market size. Further, increased R&D activities and aggressive strategies by leading competitors are driving the bio implants market. The high cost of bioimplant procedures and appropriate utilization of bioimplant products hamper the market growth.

What was the estimated bio implants market size in 2023?

The bio implants market was valued at US$ 117.82 billion in 2023.

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

The List of Companies - Bio Implants Market

  1. LifeNet Health
  2. Smith & Nephew
  3. Arthrex, Inc.
  4. Clinic Lemanic
  5. Alpha Bio Tec
  6. MiMedx Group
  7. Medtronic
  8. St Jude Medical (Abbott)
  9. Stryker Cooperation
  10. DePuy Synthes
  11. Biomet (Zimmer)
  12. Exactech, Inc.
  13. Cochlear Ltd
  14. Straumann AG

Buy Now  

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.